(Total Views: 968)
Posted On: 05/27/2020 4:43:41 PM
Post# of 72440
I was trying to help newbies on another forum and posted the below but it was deleted as being off-topic. Well done, SS, you A-hole.
For new people checking out IPIX, it has a lot to offer for both traders and investors.
Traders have made a lot of money due to the constant churning in the share price. Forces seem to want to keep the stock price contained but within a range so that money can be made almost daily as the price rises and settles back down at a fast clip. I am not a trader, don't know much about it, but over the years they have been the BIG winners to date.
As for investors, things have been rough for years due to financial concerns (nothing new when talking about a startup biotech with no products yet and drugs taking 10+ years and about $1B to see thru clinical trials) but events have started to move at a dazzling pace in the last 6 months or so and IPIX seems on the verge of finally capitalizing on its megastar drug, Brilacidin. Brilacidin is a synthetic drug, a defensin mimetic, formulated using tens of thousands of hours on super computers so its benefits are many and its drawbacks very small, if even existent.
Brilacidin is now on a pace to possibly cure all, or at least many, of the most severe lower GI tract problems to include Colitis and Crohn's Disease thru the delivery system of a pill. It is on the verge of going to a PhaseIII trial for Oral Mucositis, has already succeeded in a PhaseII antibiotic trial (ABSSSI), and is currently a leading hope to be a treatment or cure for CV19. It has had tests in governmental bio labs that established that it kills the corona virus, works on human kidney tissue in killing CV, and is nearly finished in testing on how it works regarding human lung tissue. Expectations are quite high, extremely high, for this important lung tissue test due to its past trial history. Then it will be ready for use in human CV trials and Brilacidin should become a worldwide household name. The current testing is expected to result in a lot of money (most think in the 10s of millions) granted to IPIX for furher investigation across many fields. Example: The lung testing, when shown successful, should then lead medical authorities to allow Brilacidin to be tested against COPD and Asthma. Its ability to handle CV should also make it a prime candidate as an adjuvant for ALL other virus vaccines, including the flu. To date, it has NEVER met a bacteria in trials it couldn't kill - to include black plague, about 9 different strains of anthrax, etc.
IPIX also has another drug, Kevetrin, that has shown AMAZING results to date in use as a cancer treatment or adjuvant to ALL current cancer treatments. It is the only current drug that has shown it can activate the p53 gene, named the Guardian Angel gene, as it causes the production of the body's natural defensive agents. It needs to be formulated into a pill and currently the pill is about 1/2 way thru tox tests. It is on hold due to lack of funds to proceed further at the current time. But with the expected government grants on the extremely near horizon (most expect grants within a matter of weeks if lung tissue test results are quite good) the Kevetrin pill will be able to be finished and then be put into quite a battery of trials as a stand alone and, more importantly, as an aid to all other current toxic cancer treatments.
The final piece of the puzzle for BOTH Brilacidin and Kevetrin is that besides showing trial results to date of being extremely effective (efficacious), they are also blessed with safety profiles that are so good, having next to NO negative side effects, that they are marvels in the world of medicine today.
Most the boo-hooing you hear on this board is by the traders as they live and die by the daily share price. The true investors you don't hear much from as the trial results speak for themselves. This investment could be the one of a lifetime if things progress as they have been progressing. But then nothing is ever guaranteed so being such a high risk stock be sure that you don't invest what you can't afford to lose.
For new people checking out IPIX, it has a lot to offer for both traders and investors.
Traders have made a lot of money due to the constant churning in the share price. Forces seem to want to keep the stock price contained but within a range so that money can be made almost daily as the price rises and settles back down at a fast clip. I am not a trader, don't know much about it, but over the years they have been the BIG winners to date.
As for investors, things have been rough for years due to financial concerns (nothing new when talking about a startup biotech with no products yet and drugs taking 10+ years and about $1B to see thru clinical trials) but events have started to move at a dazzling pace in the last 6 months or so and IPIX seems on the verge of finally capitalizing on its megastar drug, Brilacidin. Brilacidin is a synthetic drug, a defensin mimetic, formulated using tens of thousands of hours on super computers so its benefits are many and its drawbacks very small, if even existent.
Brilacidin is now on a pace to possibly cure all, or at least many, of the most severe lower GI tract problems to include Colitis and Crohn's Disease thru the delivery system of a pill. It is on the verge of going to a PhaseIII trial for Oral Mucositis, has already succeeded in a PhaseII antibiotic trial (ABSSSI), and is currently a leading hope to be a treatment or cure for CV19. It has had tests in governmental bio labs that established that it kills the corona virus, works on human kidney tissue in killing CV, and is nearly finished in testing on how it works regarding human lung tissue. Expectations are quite high, extremely high, for this important lung tissue test due to its past trial history. Then it will be ready for use in human CV trials and Brilacidin should become a worldwide household name. The current testing is expected to result in a lot of money (most think in the 10s of millions) granted to IPIX for furher investigation across many fields. Example: The lung testing, when shown successful, should then lead medical authorities to allow Brilacidin to be tested against COPD and Asthma. Its ability to handle CV should also make it a prime candidate as an adjuvant for ALL other virus vaccines, including the flu. To date, it has NEVER met a bacteria in trials it couldn't kill - to include black plague, about 9 different strains of anthrax, etc.
IPIX also has another drug, Kevetrin, that has shown AMAZING results to date in use as a cancer treatment or adjuvant to ALL current cancer treatments. It is the only current drug that has shown it can activate the p53 gene, named the Guardian Angel gene, as it causes the production of the body's natural defensive agents. It needs to be formulated into a pill and currently the pill is about 1/2 way thru tox tests. It is on hold due to lack of funds to proceed further at the current time. But with the expected government grants on the extremely near horizon (most expect grants within a matter of weeks if lung tissue test results are quite good) the Kevetrin pill will be able to be finished and then be put into quite a battery of trials as a stand alone and, more importantly, as an aid to all other current toxic cancer treatments.
The final piece of the puzzle for BOTH Brilacidin and Kevetrin is that besides showing trial results to date of being extremely effective (efficacious), they are also blessed with safety profiles that are so good, having next to NO negative side effects, that they are marvels in the world of medicine today.
Most the boo-hooing you hear on this board is by the traders as they live and die by the daily share price. The true investors you don't hear much from as the trial results speak for themselves. This investment could be the one of a lifetime if things progress as they have been progressing. But then nothing is ever guaranteed so being such a high risk stock be sure that you don't invest what you can't afford to lose.
(19)
(0)Scroll down for more posts ▼
